X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/khondrion-announces-grant-of-patents-in-the-us-and-europe-for-its-lead-candidate-sonlicromanol-covering-the-anti-inflammatory-effect-on-mpges-1-301973246.html
https://www.fiercebiotech.com/biotech/clutching-post-hoc-analyses-khondrion-forges-despite-phase-2-mitochondrial-disease-fail
https://www.globenewswire.com//news-release/2022/11/22/2560649/0/en/Khondrion-announces-sonlicromanol-Phase-IIb-progress-supporting-Phase-III-development-in-MELAS-spectrum-disorders.html
https://www.globenewswire.com/news-release/2022/01/10/2363559/0/en/Khondrion-completes-enrolment-in-KHENERGYZE-Phase-IIb-trial-evaluating-sonlicromanol-in-adult-patients-with-MELAS-spectrum-disorders.html
https://kadans.com/khondrion-moves-headquarters-to-novio-tech-campus-to-support-growth/?lang=en
https://www.globenewswire.com/news-release/2021/04/21/2213990/0/en/Khondrion-announces-first-patients-dosed-in-6-month-paediatric-Phase-II-study-of-sonlicromanol-for-mitochondrial-diseases.html
https://www.globenewswire.com/news-release/2021/01/18/2159727/0/en/Khondrion-receives-EMA-agreement-on-its-Paediatric-Investigation-Plan-for-sonlicromanol.html
https://www.pharmiweb.com/press-release/2021-01-13/khondrion-announces-publication-in-scientific-reports-outlining-an-additional-anti-inflammatory-mode-of-action-for-its-lead-phase-iib-stage-drug-candi
https://www.pharmiweb.com/press-release/2020-11-30/khondrion-shares-progress-of-sonlicromanol-development-programme-at-mitochondrial-medicine-2020-virtual-conference
Market Place
Share 
